Immediate Impact

54 standout
Sub-graph 1 of 22

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia
2024 Standout
1 intermediate paper

Works of Luke Boulanger being referenced

Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study
2013
Potential Short-Term Economic Benefits of Improved Glycemic Control
2001

Author Peers

Author Last Decade Papers Cites
Luke Boulanger 167 180 317 249 197 67 1.4k
C. Droz‐Perroteau 116 92 262 340 99 87 1.6k
Marion Bertrand 123 196 285 163 91 48 1.4k
Jason J. Sico 50 204 217 192 112 89 1.3k
Moshe Hoshen 68 99 341 215 159 66 1.6k
Suzanne M. Lloyd 132 80 389 292 196 40 1.7k
Edouard L. Fu 118 86 420 331 289 81 1.5k
Michèle Dramaix Wilmet 48 84 475 166 205 47 1.4k
Andrew Maguire 72 70 290 138 126 41 1.3k
Pirjo Immonen‐Räihä 113 72 690 219 108 42 1.7k
Ajay Bhalla 73 181 250 279 66 71 1.5k

All Works

Loading papers...

Rankless by CCL
2026